- Allow approved researchers access to member contributed datasets in a scalable, reproducible, privacy and security protected manner as part of the Consortium’s collaborative effort.
- Access to samples while working in collaboration with the Department of Defense and Applied Proteogenomics OrganizationaL Learning and Outcomes (APOLLO) network.
- The ability to mold and influence the development of assays through a collaborative relationship with the FDA Oncology Center of Excellence, and the leadership of the Associate Director, Office of Hematology Oncology FDA and the CDRH Director.
- The opportunity to establish best practices and principles to incorporate into operating procedures and eliminate duplication of efforts.
- Foster the development and enhancement of relationships across all stakeholders in the field – pharmaceutical companies, technology companies, academic institutions, foundations, patient advocacy groups, physicians and government agencies.
To join the BloodPAC, please review the documents below and return a signed copy of the BloodPAC Membership Agreement to info at bloodpac-data.org.